A transgenic rat model of Alzheimer's disease with extracellular Aβ deposition

Neurobiology of Aging

Volumn 30, Issue 7, 2009, Pages 1078-1090

  Flood, Dorothy G ^a   Lin, Yin Guo ^a   Lang, Diane M ^a   Trusko, Stephen P ^a   Hirsch, James D ^a   Savage, Mary J ^a   Scott, Richard W ^a   Howland, David S ^a  

^a CEPHALON INC   (United States)

Author keywords

A deposition; Alzheimer's disease; Amyloid; Animal model; Phosphorylated tau; Presenilin; Rat; Reactive gliosis; Transgenic

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; PRESENILIN 1; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE MUTATION; GLIA; HOMOZYGOSITY; MOUSE; NONHUMAN; ONSET AGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAT; SPRAGUE DAWLEY RAT; TRANSGENE; TRANSGENIC MOUSE; TRANSGENIC RAT;

AGE OF ONSET; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BIOLOGICAL MARKERS; BRAIN; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR FLUID; GLIOSIS; HUMANS; MICE; MICE, TRANSGENIC; MUTATION; NEUROFIBRILLARY TANGLES; PHOSPHORYLATION; PRESENILIN-1; RATS; RATS, SPRAGUE-DAWLEY; RATS, TRANSGENIC; SENILE PLAQUES; TAU PROTEINS; TRANSGENES;

EID: 65649086472     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2007.10.006     Document Type: Article

References (41)

1. Annaert W.G., Levesque L., Craessaerts K., Dierinck I., Snellings G., Westaway D., St George-Hyslop P., Cordell B., Fraser P., and De Strooper B. Presenilin 1 controls γ-secretase processing of amyloid precursor protein in pre-Golgi compartments of hippocampal neurons. J. Cell. Biol. 147 (1999) 277-294
2. Bloom F.E., Reilly J.F., Redwine J.M., Wu C.-C., Young W.G., and Morrison J.H. Mouse models of human neurodegenerative disorders. Requirements for medication development. Arch. Neurol. 62 (2005) 185-187
3. Cai X.-D., Golde T.E., and Younkin S.G. Release of excess amyloid β protein from a mutant amyloid β protein precursor. Science 259 (1993) 514-516
4. Citron M., Oltersdorf T., Haass C., McConologue L., Hung A.Y., Seubert P., Vigo-Pelfrey C., Lieberburg I., and Selkoe D.J. Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production. Nature 360 (1992) 672-674
5. 40: evidence from cats and dogs. Neurobiol. Aging 17 (1996) 653-659
6. Czech C., Lesort M., Tremp G., Terro F., Blanchard V., Schombert B., Carpentier N., Dreisler S., Bonici B., Takashima A., Moussaoui S., Hugon J., and Pradier L. Characterization of human presenilin 1 transgenic rats: increased sensitivity to apoptosis in primary neuronal cultures. Neuroscience 87 (1998) 325-336
7. Echeverria V., Ducatenzeiler A., Alhonen L., Janne J., Grant S.M., Wandosell F., Muro A., Baralle F., Li H., Duff K., Szyf M., and Cuello A.C. Rat transgenic models with a phenotype of intracellular Aβ accumulation in hippocampus and cortex. J. Alz. Dis. 6 (2004) 209-219
8. Echeverria V., Ducatenzeiler A., Dowd E., Jänne J., Grant S.M., Szyf M., Wandosell F., Avila J., Grimm H., Dunnett S.B., Hartmann T., Alhonen L., and Cuello A.C. Altered mitogen-activated protein kinase signaling, tau hyperphosphorylation and mild spatial learning dysfunction in transgenic rats expressing the β-amyloid peptide intracellularly in hippocampal and cortical neurons. Neuroscience 129 (2004) 583-592
9. Falinska A.M., Marshall V.J., and Chapman P.F. The effects of high-cholesterol diet on behavior and synaptic physiology in βAPP transgenic rats. Soc. Neurosci. Abstr. 28 (2002) 191.2
10. Flood D.G., Reaume A.G., Dorfman K.S., Lin Y.-G., Lang D.M., Trusko S.P., Savage M.J., Annaert W.G., De Strooper B., Siman R., and Scott R.W. FAD mutant PS-1 gene-targeted mice: increased Aβ42 and Aβ deposition without APP overproduction. Neurobiol. Aging 23 (2002) 335-348
11. Flood D.G., Reaume A.G., Gruner J.A., Hoffman E.A., Hirsch J.D., Lin Y.-G., Dorfman K.S., and Scott R.W. Hindlimb motor neurons require Cu/Zn superoxide dismutase for maintenance of neuromuscular junctions. Am. J. Pathol. 155 (1999) 663-672
12. Folkesson R., Malkiewicz K., Kloskowsk E., Nilsson T., Popova E., Bogdanovic N., Ganten U., Ganten D., Bader M., Winblad B., and Benedikz E. A transgenic rat expressing human APP with the Swedish Alzheimer's disease mutation. Biochem. Biophys. Res. Commun. 358 (2007) 777-782
13. Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C., Carr T., Clemens J., Donaldson T., Gillespie F., Guido T., Hagopian S., Johnson-Wood K., Khan K., Lee M., Leibowitz P., Lieberburg I., Little S., Masliah E., McConlogue L., Montoya-Zavala M., Mucke L., Paganini L., Penniman E., Power M., Schenk D., Seubert P., Snyder B., Soriano F., Tan H., Vitale J., Wadsworth S., Wolozin B., and Zhao J. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373 (1996) 523-528
14. Giannakopoulos P., Silhol S., Jallageas V., Mallet J., Bons N., Bouras C., and Delaere P. Quantitative analysis of tau protein-immunoreactive accumulations and beta amyloid protein deposits in the cerebral cortex of the mouse lemur, Microcebus murinus. Acta Neuropathol. (Berl) 94 (1997) 131-139
15. Hardy J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci. 20 (1997) 154-159
16. Hoesche C., Sauerwald A., Veh R.W., Krippl B., and Killimann M.W. The 5′-flanking region of the rat synapsin I gene directs neuron-specific, and developmentally regulated reporter gene expression in transgenic mice. J. Biol. Chem. 268 (1993) 26494-26502
17. Hogan B., Constantini F., and Lacy E. Manipulating the Mouse Embryo: A Laboratory Manual (1986), Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
18. Howland D.S., Savage M.S., Huntress F.A., Wallace R.E., Schwartz D.A., Loh T., Melloni Jr. R.H., DeGennaro L.J., Greenberg B.D., Siman R., Swanson M.E., and Scott R.W. Mutant and native human β-amyloid precursor proteins in transgenic mouse brain. Neurobiol. Aging 16 (1995) 685-699
19. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., and Cole G. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 274 (1996) 99-102
20. Jankowsky J.L., Savonenko A., Schilling G., Wang J., Xu G., and Borchelt D.R. Transgenic mouse models of neurodegenerative disease: opportunities for therapeutic development. Curr. Neurol. Neurosci. Rep. 2 (2002) 457-464
21. Lopez E.M., Bell K.F.S., Ribeiro-da-Silva A., and Cuello A.C. Early changes in neurons of the hippocampus and neocortex in transgenic rats expression intracellular human A-β. J. Alz. Dis. 6 (2004) 421-431
22. Loring J.F., Paszty C., Rose A., McIntosh T.K., Murai H., Pierce J.E.S., Schramm S.R., Wymore K., Lee V.M.-Y., Trojanowski J.Q., and Peterson K.R. Rational design of an animal model for Alzheimer's disease: introduction of multiple human genomic transgenes to reproduce AD pathology in a rodent. Neurobiol. Aging 17 (1996) 173-182
23. Marshall V.J., Hsiao K.K., and Chapman P.F. The production of a rat model of Alzheimer's disease. Soc. Neurosci. Abstr. 25 (1999) 741.16
24. Pybus R., Barnard E., Estibeiro P., Mullins J., and MacLeod N. Enhanced long-term potentiation in the hippocampus of rats expressing mutant presenilin-1 is age related. Neurobiol. Dis. 12 (2003) 212-224
25. Quon D., Wang Y., Catalano R., Scardina J.M., Murakami K., and Cordell B. Formation of β-amyloid protein deposits in brains of transgenic mice. Nature 352 (1991) 239-241
26. Ruiz-Opazo N., Kosik K.S., Lopez L.V., Bagamasbad P., Ponce L.R.B., and Herrera V.L.M. Attenuated hippocampus-dependent learning and memory decline in transgenic TgAPPswe Fischer-344 rats. Mol. Med. 10 (2004) 36-44
27. Sasahara M., Fries J.W., Raines E.W., Gown A.M., Westrum L.E., Frosch M.P., Bonthron D.T., Ross R., and Collins T. PDGF-β chain in neurons of the central nervous system, posterior pituitary, and in a transgenic model. Cell 64 (1991) 217-227
28. Sasahara M., Sato H., IIhara K., Wang J., Chue C.H., Takayama S., Hayase Y., and Hazama F. Expression of platelet-derived growth factor β-chain in the mature rat brain and pituitary gland. Brain Res. Mol. Brain Res. 32 (1995) 63-74
29. Savage M.J., Iqbal M., Loh T., Trusko S.P., Scott R., and Siman R. Cathepsin G: localization in human cerebral cortex and generation of amyloidogenic fragments from the β-amyloid precursor protein. Neuroscience 60 (1994) 607-619
30. Savage M.J., Lin Y.-G., Ciallella J.R., Flood D.G., and Scott R.W. Activation of c-Jun N-terminal kinase and p38 in an Alzheimer's disease model is associated with amyloid deposition. J. Neurosci. 22 (2002) 3376-3385
31. Savage M.J., Trusko S.P., Howland D.S., Pinsker L.R., Mistretta S., Reaume A.G., Greenberg B.D., Siman R., and Scott R.W. Turnover of amyloid β-protein in mouse brain and acute reduction of its level by phorbol ester. J. Neurosci. 18 (1998) 1743-1752
32. Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., Bird T.D., Hardy J., Hutton M., Kukull W., Larson E., Levy-Lehad E., Viitanen M., Peskind E., Poorkaj P., Schellenberg G., Tanzi R., Wasco W., Lannfelt L., Selkoe D., and Younkin S. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 2 (1996) 864-870
33. Selkoe D.J. The molecular pathology of Alzheimer's disease. Neuron 6 (1991) 487-498
34. Selkoe D.J. The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell. Biol. 8 (1998) 447-453
35. Selkoe D.J. Alzheimer's disease is a synaptic failure. Science 298 (2002) 789-791
36. Selkoe D.J., Bell D.S., Podlisny M.B., Price D.L., and Cork L.C. Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease. Science 235 (1987) 873-877
37. Siman R., Reaume A.G., Savage M.J., Trusko S., Lin Y.-G., Scott R.W., and Flood D.G. Presenilin-1 P264L knock-in mutation: differential effects on Aβ production, amyloid deposition, and neuronal vulnerability. J. Neurosci. 20 (2000) 8717-8726
38. Spires T.L., and Hyman B.T. Transgenic models of Alzheimer's disease: learning from animals. NeuroRx 2 (2005) 423-437
39. Sturchler-Pierrat C., Abramowski D., Duke M., Wiederhold K.-H., Mistl C., Rothacher S., Ledermann B., Bürki K., Frey P., Paganetti P.A., Waridel C., Calhoun M.E., Jucker M., Probst A., Staufenbiel M., and Sommer B. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 13287-13292
40. 717) mutants. Science 264 (1994) 1336-1340
41. Vercauteren F.G.G., Clerens S., Roy L., Hamel N., Arckens L., Vandesande F., Alhonen L., Janne J., Szyf M., and Cuello A.C. Early dysregulation of hippocampal proteins in transgenic rats with Alzheimer's disease-linked mutations in amyloid precursor protein and presenilin 1. Mol. Brain Res. 132 (2004) 241-259